EBR Systems, Inc. (ASX: EBR) has received FDA approval of the WiSE® System, which marks a significant leap forward in the treatment of heart failure. Unlike conventional CRT, the WiSE System is the ...

EBR designed its WiSE system to significantly expand the population of patients who could benefit from CRT. The leadless ...

Wide complexes; because they come from the ventricles and do not use the normal ventricular conduction system, action potentials need to travel from myocyte to myocyte, which is much slower ...

Imricor Medical Systems announced that it commenced a trial by completing its first-in-human ventricular ablation procedure.